BCRX
Price
$7.45
Change
+$0.39 (+5.52%)
Updated
Jan 17 closing price
Capitalization
1.54B
31 days until earnings call
CGTX
Price
$0.68
Change
-$0.01 (-1.45%)
Updated
Jan 17 closing price
Capitalization
28.33M
67 days until earnings call
Ad is loading...

BCRX vs CGTX

Header iconBCRX vs CGTX Comparison
Open Charts BCRX vs CGTXBanner chart's image
BioCryst Pharmaceuticals
Price$7.45
Change+$0.39 (+5.52%)
Volume$3.96M
Capitalization1.54B
Cognition Therapeutics
Price$0.68
Change-$0.01 (-1.45%)
Volume$655.13K
Capitalization28.33M
BCRX vs CGTX Comparison Chart
Loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCRX vs. CGTX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCRX is a Hold and CGTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (BCRX: $7.45 vs. CGTX: $0.68)
Brand notoriety: BCRX: Notable vs. CGTX: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCRX: 196% vs. CGTX: 6%
Market capitalization -- BCRX: $1.54B vs. CGTX: $28.33M
BCRX [@Biotechnology] is valued at $1.54B. CGTX’s [@Biotechnology] market capitalization is $28.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCRX’s FA Score shows that 1 FA rating(s) are green whileCGTX’s FA Score has 1 green FA rating(s).

  • BCRX’s FA Score: 1 green, 4 red.
  • CGTX’s FA Score: 1 green, 4 red.
According to our system of comparison, BCRX is a better buy in the long-term than CGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCRX’s TA Score shows that 5 TA indicator(s) are bullish while CGTX’s TA Score has 2 bullish TA indicator(s).

  • BCRX’s TA Score: 5 bullish, 3 bearish.
  • CGTX’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, BCRX is a better buy in the short-term than CGTX.

Price Growth

BCRX (@Biotechnology) experienced а -2.87% price change this week, while CGTX (@Biotechnology) price change was -10.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

BCRX is expected to report earnings on May 07, 2025.

CGTX is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCRX($1.54B) has a higher market cap than CGTX($28.3M). BCRX YTD gains are higher at: -0.931 vs. CGTX (-2.781). BCRX has higher annual earnings (EBITDA): -24.12M vs. CGTX (-33.98M). BCRX has more cash in the bank: 330M vs. CGTX (22M). CGTX has less debt than BCRX: CGTX (580K) vs BCRX (809M). BCRX has higher revenues than CGTX: BCRX (413M) vs CGTX (0).
BCRXCGTXBCRX / CGTX
Capitalization1.54B28.3M5,452%
EBITDA-24.12M-33.98M71%
Gain YTD-0.931-2.78133%
P/E RatioN/AN/A-
Revenue413M0-
Total Cash330M22M1,500%
Total Debt809M580K139,483%
FUNDAMENTALS RATINGS
BCRX: Fundamental Ratings
BCRX
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCRXCGTX
RSI
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
84%
Bearish Trend 11 days ago
84%
Momentum
ODDS (%)
Bullish Trend 11 days ago
86%
N/A
MACD
ODDS (%)
Bullish Trend 11 days ago
88%
N/A
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 11 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 11 days ago
80%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 13 days ago
80%
Declines
ODDS (%)
Bearish Trend 19 days ago
80%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 11 days ago
85%
View a ticker or compare two or three
Ad is loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TAGHX30.820.34
+1.12%
Transamerica US Growth R6
JGVVX43.650.40
+0.92%
JPMorgan Growth Advantage R6
RIVCX13.430.06
+0.45%
Victory RS Investors C
IJMSX16.310.04
+0.25%
VY® JPMorgan Mid Cap Value S
WBEIX12.66N/A
N/A
William Blair Emerging Mkts Growth I

CGTX and

Correlation & Price change

A.I.dvisor tells us that CGTX and ALRN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CGTX and ALRN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGTX
1D Price
Change %
CGTX100%
-1.80%
ALRN - CGTX
29%
Poorly correlated
N/A
VTVT - CGTX
29%
Poorly correlated
+0.04%
BRCTF - CGTX
28%
Poorly correlated
N/A
BCRX - CGTX
28%
Poorly correlated
+5.52%
NNVC - CGTX
26%
Poorly correlated
-0.83%
More